Kircik LH |
Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. |
2011 |
J Drugs Dermatol |
pmid:21637899
|
Wheeland RG and Dhawan S |
Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. |
2011 |
J Drugs Dermatol |
pmid:21637900
|
Que SK and Bergstrom KG |
Hyperpigmentation: old problem, new therapies. |
2009 |
J Drugs Dermatol |
pmid:19746682
|
Thiboutot DM et al. |
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. |
2009 |
J Drugs Dermatol |
pmid:19588640
|
Del Rosso JQ et al. |
Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. |
2010 |
J Drugs Dermatol |
pmid:20645521
|
Ziel K et al. |
Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. |
2005 Nov-Dec |
J Drugs Dermatol |
pmid:16302558
|
Fleischer A and Suephy C |
The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. |
2005 Sep-Oct |
J Drugs Dermatol |
pmid:16167417
|
Thiboutot DM et al. |
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. |
2008 |
J Drugs Dermatol |
pmid:18561584
|
Bhatia ND and Del Rosso JQ |
Optimal management of papulopustular rosacea: rationale for combination therapy. |
2012 |
J Drugs Dermatol |
pmid:22777226
|
Del Rosso JQ and Kircik LH |
Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. |
2014 |
J Drugs Dermatol |
pmid:25607798
|
Woolery-Lloyd HC et al. |
Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color. |
2013 |
J Drugs Dermatol |
pmid:23652891
|
Manosroi A et al. |
Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines. |
2007 |
J Drug Target |
pmid:17541842
|
Choi YS et al. |
A study of the efficacy of cleansers for acne vulgaris. |
2010 |
J Dermatolog Treat |
pmid:20394494
|
Pazoki-Toroudi H et al. |
Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. |
2010 |
J Dermatolog Treat |
pmid:20394495
|
Asai Y et al. |
Canadian Clinical Practice Guidelines for Rosacea. |
2016 |
J Cutan Med Surg |
pmid:27207355
|
Patwardhan N |
Conference Report: ACSICON 2008. |
2009 |
J Cutan Aesthet Surg |
pmid:20300376
|
Esposito E et al. |
Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. |
2004 May-Jun |
J Cosmet Sci |
pmid:15264053
|
Lee GS |
Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. |
2008 |
J Cosmet Laser Ther |
pmid:18830869
|
Draelos ZD et al. |
An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. |
2006 |
J Cosmet Dermatol |
pmid:17173568
|
Farshi S |
Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. |
2011 |
J Cosmet Dermatol |
pmid:22151936
|
Arizaga GG et al. |
Chemical modification of zinc hydroxide nitrate and Zn-Al-layered double hydroxide with dicarboxylic acids. |
2008 |
J Colloid Interface Sci |
pmid:18243238
|
Jones DA |
Rosacea, reactive oxygen species, and azelaic Acid. |
2009 |
J Clin Aesthet Dermatol |
pmid:20967185
|
McFalda WL and Roebuck HL |
Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report. |
2011 |
J Clin Aesthet Dermatol |
pmid:21278898
|
Del Rosso JQ |
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. |
2009 |
J Clin Aesthet Dermatol |
pmid:20729951
|
Davis EC and Callender VD |
Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. |
2010 |
J Clin Aesthet Dermatol |
pmid:20725554
|
Salimon J et al. |
Synthesis and physical properties of estolide ester using saturated Fatty Acid and ricinoleic Acid. |
2011 |
J Autom Methods Manag Chem |
pmid:22007150
|
Maes M et al. |
Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. |
2013 |
J Affect Disord |
pmid:22898471
|
Verma P and Pathak K |
Therapeutic and cosmeceutical potential of ethosomes: An overview. |
2010 |
J Adv Pharm Technol Res |
pmid:22247858
|
Chudasama A et al. |
Investigation of microemulsion system for transdermal delivery of itraconazole. |
2011 |
J Adv Pharm Technol Res |
pmid:22171289
|
Karimi AA et al. |
Improvement of tissue survival of skin flaps by 5α-reductase inhibitors: possible involvement of nitric oxide and inducible nitric oxide synthase. |
2015 |
Iran. Biomed. J. |
pmid:25864816
|
Breathnach AS et al. |
Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture. |
1989 |
Invest. Ophthalmol. Vis. Sci. |
pmid:2925320
|
Le Lay C et al. |
Identification and quantification of antifungal compounds produced by lactic acid bacteria and propionibacteria. |
2016 |
Int. J. Food Microbiol. |
pmid:27350657
|
Gupta AK and Gover MD |
Azelaic acid (15% gel) in the treatment of acne rosacea. |
2007 |
Int. J. Dermatol. |
pmid:17472690
|
Baliña LM and Graupe K |
The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. |
1991 |
Int. J. Dermatol. |
pmid:1816137
|
Nguyen QH and Bui TP |
Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. |
1995 |
Int. J. Dermatol. |
pmid:7737781
|
RodrÃguez Prieto MA et al. |
Treatment of lentigo maligna with azelaic acid. |
1993 |
Int. J. Dermatol. |
pmid:8505164
|
Vereecken P and Heenen M |
Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%. |
2002 Jan-Feb |
Int. J. Clin. Pract. |
pmid:11831841
|
Li N et al. |
Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. |
2010 |
Int J Pharm |
pmid:20025951
|
Manosroi J et al. |
Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. |
2005 |
Int J Pharm |
pmid:15778061
|
Karavelidis V et al. |
Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. |
2011 |
Int J Nanomedicine |
pmid:22162659
|
Smit N et al. |
The hunt for natural skin whitening agents. |
2009 |
Int J Mol Sci |
pmid:20054473
|
Ebanks JP et al. |
Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. |
2009 |
Int J Mol Sci |
pmid:19865532
|
Sarkar R et al. |
Newer and upcoming therapies for melasma. |
2012 Jul-Aug |
Indian J Dermatol Venereol Leprol |
pmid:22772611
|
Iraji F et al. |
Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. |
2007 Mar-Apr |
Indian J Dermatol Venereol Leprol |
pmid:17456913
|
Khanna N and Rasool S |
Facial melanoses: Indian perspective. |
2011 Sep-Oct |
Indian J Dermatol Venereol Leprol |
pmid:21860153
|
Ghosh S |
Chemical leukoderma: what's new on etiopathological and clinical aspects? |
2010 Jul-Sep |
Indian J Dermatol |
pmid:21063518
|
Safoury OS et al. |
A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. |
2009 |
Indian J Dermatol |
pmid:20049268
|
Rathi SK |
Acne vulgaris treatment : the current scenario. |
2011 |
Indian J Dermatol |
pmid:21572783
|
Bandyopadhyay D |
Topical treatment of melasma. |
2009 |
Indian J Dermatol |
pmid:20101327
|
Panyosak A et al. |
Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles. |
2009 |
Hum Exp Toxicol |
pmid:19755450
|